Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The Short Answer for Operators This Week
Three federal facts belong at the top of every treatment center operator’s Q1 planning file: the 2024 MHPAEA final rule took effect on November 22, 2024; Mertz Taggart counted 99 mental-health transactions and 36 addiction-treatment transactions for full-year 2024; and DOJ collected $16,663,918 from Acadia Healthcare over medically unnecessary inpatient behavioral health services. If you run a treatment center in Florida, Tennessee, Arizona, or Ohio, those three data points should reshape what your COO and your CFO are doing between now and December 31.
The Departments of Treasury, Labor, and HHS jointly issued the MHPAEA final rule on September 9, 2024. The Federal Register notice sets the effective date as November 22, 2024, with staggered applicability starting with plan years on or after January 1, 2025. Mertz Taggart’s Q4 2024 report logged 25 Q4 mental-health deals and 8 Q4 addiction-treatment deals. DOJ announced that Acadia would pay $16,663,918 to the United States plus $3,186,082 to Florida, Georgia, Michigan, and Nevada.
None of these are abstractions. Each one changes what a founder, COO, or PE sponsor should be doing before year end.
MHPAEA: The November 22 Effective Date Payers Are Already Quoting Back to You
CMS, DOL, and Treasury finalized the rule on September 9, 2024. The core operator-relevant piece: nonquantitative treatment limitations (NQTLs) around network composition, prior authorization, and out-of-network reimbursement methodology cannot be more restrictive for mental health and SUD benefits than for medical or surgical benefits.
The Departments were unambiguous about the intent. Regulators wrote that the final rules seek to make sure people who seek treatment for covered MH or SUD conditions “do not face greater burdens on access to benefits” than they would face for a medical condition or surgical procedure, per the CMS summary of the final rules. That is not aspirational language. Commercial payers in Florida, Tennessee, and Arizona are quoting it back to us during utilization management appeals right now.
What operators should do this week:
- Pull denial data by level of care (residential, PHP at ASAM Level 2.5 as an outpatient service, IOP at Level 2.1) and look for patterns showing an NQTL applied more restrictively to SUD than to a medical benchmark.
- Document concurrent review turnaround times so the data is ready when a payer’s SIU audit or a state parity complaint lands.
- Refresh your CAA 2021 comparative analysis file. Under the final rule, participants can request a copy and trigger a disclosure obligation on the plan.
One important update: on May 15, 2025, DOL, HHS, and Treasury said they would not enforce portions of the 2024 rule that are new relative to the 2013 rule while ERISA Industry Committee litigation plays out. The Departments were explicit that “MHPAEA’s statutory obligations, as amended by the CAA, 2021, continue to have effect.” Comparative analyses remain a live obligation.
The M&A Data: Fewer Deals, Bigger Checks, More Selective Buyers
Buyers are still writing checks. They are writing bigger ones. They are also being pickier about which platforms they will underwrite.
The Q4 2024 Mertz Taggart report is the cleanest read of the moment. Their team counted 25 mental-health transactions in Q4 2024, bringing the full-year total to 99, and reported 8 addiction-treatment deals in Q4 on 36 for the year, a modest increase from 29 in 2023 but still nowhere near the 79 addiction-treatment deals completed in 2021. Managing Partner Kevin Taggart put it plainly: “Buyers who had been sitting on the sidelines for a while reached out to us late in Q4 to catch up before the new year.”
The private-equity picture matters more than the quarterly count. A JAMA Psychiatry study by Zhu, Greenberg, King, and Busch, published May 1, 2024, identified 642 mental health clinics and 1,152 SUD clinics acquired by private equity through their study period, representing 6.2% of mental health facilities and 7.1% of addiction treatment facilities nationwide. In Colorado, Texas, and North Carolina, PE-owned practices already account for roughly a quarter of facilities providing mental health treatment.
What this means if you are considering a sale in Florida, Tennessee, or Ohio: the buyers looking at your business right now are more disciplined than the 2021 cohort. They will read your denials, your census trend by payer, your clinical staffing ratios, and your accreditation history before anyone debates multiple. If your operational backbone is weak, a quality of earnings team will find it.
Federal Enforcement: Acadia, and What Surveyors Are Watching
The Department of Justice recouped more than $2.9 billion under the False Claims Act in fiscal year 2024, with nearly $1.7 billion tied to healthcare. Behavioral health was on the list.
Acadia Healthcare agreed to pay $16,663,918 to the United States plus $3,186,082 to Florida, Georgia, Michigan, and Nevada to resolve False Claims Act allegations that six of its facilities billed Medicare, Medicaid, and TRICARE for medically unnecessary inpatient behavioral health services between 2014 and 2017. DOJ also alleged that Acadia “failed to provide adequate staffing, training and/or supervision of staff, which resulted in assaults, elopements, suicides and other harm.” Principal Deputy Assistant Attorney General Brian M. Boynton said the department places “a high priority on fighting fraud and abuse in federal programs.”
One common thread across recent enforcement: documentation and clinical judgment that could not withstand a regulator reading the chart line by line. If you run a residential or PHP program, treat this settlement as your surveyor focus list for 2025:
- Medical necessity documentation tied to the ASAM Criteria (Fourth Edition) level-of-care assignment, with a defensible reason for each continued stay.
- Discharge planning that reflects a real clinical decision, not a census management tool.
- Staffing ratios that match what your license and accreditation standards require, not what your labor budget wishes were true.
- Controlled substance prescribing workflows that hold up to DEA review.
What Operators Should Do Before Year End
This is a five-item list, not a strategy deck:
- Refresh your MHPAEA comparative analysis file. The CAA 2021 obligation is not paused. When a payer or state regulator asks, you should be able to hand it over inside 48 hours.
- Run a mock survey on medical necessity and discharge documentation before any surveyor books an EOC tour. The Acadia settlement is a preview of what a serious surveyor or SIU auditor is looking for.
- Rebuild your pro forma with 2025 payer assumptions, not 2022 assumptions. If your feasibility study still uses pre-pandemic reimbursement and length-of-stay numbers, it is fiction.
- Get a diligence-ready compliance program and financial package built now if you are considering a transaction. Buyers in Florida, Tennessee, and Ohio are moving faster on clean assets and walking away from messy ones.
- Name your operational backbone weaknesses out loud to your leadership team. Founders who let their COOs work around a broken UM process for another quarter are the ones who show up in the next enforcement release.
Operators who spent November 2024 quietly tightening documentation and payer readiness will be the ones with a real growth story in 2025. Owners who treated the news as background noise will be the ones explaining to a buyer, or a regulator, why the file does not match the pitch deck.
Frequently asked questions
When did the 2024 MHPAEA final rule take effect, and does it still apply to my treatment center?
The 2024 MHPAEA final rule, issued jointly by DOL, HHS, and Treasury on September 9, 2024, became effective November 22, 2024, with staggered applicability starting with plan years on or after January 1, 2025 for group health plans and January 1, 2026 for individual market plans. On May 15, 2025, the Departments announced they would not enforce the portions of the 2024 rule that are new relative to the 2013 rule while ERISA Industry Committee litigation plays out, but they were explicit that MHPAEA’s statutory obligations under the CAA 2021, including the NQTL comparative analysis requirement, continue to have effect. Operators should keep treating comparative analyses and network adequacy as active compliance obligations.
What did behavioral health M&A actually look like in Q4 2024?
Per Mertz Taggart’s Q4 2024 Behavioral Health M&A Report, the fourth quarter of 2024 saw 25 deals involving mental healthcare providers, bringing the full-year mental health total to 99 transactions. The report also logged 8 addiction-treatment deals in Q4 on 36 for the year, up modestly from 29 in 2023 but well below the 79 addiction-treatment deals completed in 2021. Managing Partner Kevin Taggart noted that buyers who had been on the sidelines were reaching out again late in Q4.
What should operators take from the Acadia Healthcare $16.66 million settlement?
DOJ announced that Acadia Healthcare agreed to pay $16,663,918 to the United States, plus $3,186,082 to Florida, Georgia, Michigan, and Nevada, to resolve False Claims Act allegations that six of its facilities billed Medicare, Medicaid, and TRICARE for medically unnecessary inpatient behavioral health services between 2014 and 2017. DOJ also alleged Acadia failed to provide adequate staffing, discharge planning, and active treatment. For treatment center operators, the practical takeaway is that medical necessity documentation aligned to ASAM Criteria (Fourth Edition), defensible discharge decisions, and staffing that matches licensure and accreditation requirements are enforcement priorities, not paperwork exercises.
How much of the behavioral health sector is owned by private equity?
A May 2024 JAMA Psychiatry study by Zhu, Greenberg, King, and Busch identified 642 mental health clinics and 1,152 SUD clinics acquired by private equity between January 2012 and July 2023, representing 6.2% of mental health facilities and 7.1% of addiction treatment facilities nationwide, with significant state-by-state variation. In Colorado, Texas, and North Carolina, PE-owned practices already account for roughly a quarter of all facilities providing mental health treatment. The study did not measure quality of care or cost outcomes.
References
- Federal Register: Requirements Related to the Mental Health Parity and Addiction Equity Act (Sept. 23, 2024)
- CMS: The Mental Health Parity and Addiction Equity Act (MHPAEA)
- U.S. Department of Labor: Statement Regarding Enforcement of the 2024 MHPAEA Final Rule (May 15, 2025)
- DOJ: Acadia Healthcare Company Inc. To Pay $19.85M to Settle Allegations Relating to Medically Unnecessary Inpatient Behavioral Health Services
- Mertz Taggart: Q4 2024 Behavioral Health M&A Report
- OHSU News: Study Finds Private Equity Expanding to Mental Health Facilities (JAMA Psychiatry, Zhu et al., May 2024)
- Fierce Healthcare: DOJ Secured $1.7B from Healthcare False Claims Settlements in FY24